Pre-BSAVA meeting, April 2006

   Minimise

Wednesday, 19 April 2006, Hall 10, ICC Birmingham

We have endeavored to ensure a strong clinical emphasis, and an excellent line-up of speakers from both the US and Europe:

PROGRAMME
8:30 - 9:00 Registration
9:00 - 9:25 Update on NT pro-BNP research
Adrian Boswood, RVC
9:25 - 10:25 NOVARTIS SOTA lecture
Management of asymptomatic chronic mitral valve disease in dogs
Clarke Atkins, USA
10:25 - 10:50 Clinical efficacy of pimobendan in comparison to benazepril and metildigoxin in Irish wolfhounds with preclinical DCM. Interim analysis after year 4 of the study
Andrea Vollmar, Germany
Sponsored by Boehringer Ingelheim
10:50 - 11:20 Coffee Break
11:20 - 11.45 Update on the reliability regarding the detection of systemic hypertension - latest research findings
Beate Egner, Germany
11:45 - 12:15 Assessment of cardiovascular disease in 555 boxer dogs
Andrea Vollmar, Germany
Sponsored by Boehringer Ingelheim
12:15 - 12:45 Survival characteristics in >1000 Irish wolfhounds. Prevalence of DCM and effect on life expectancy
Andrea Vollmar, Germany
Sponsored by Boehringer Ingelheim
12:45 - 2:00 Lunch
2:00 - 2:25 Heart failure in feline diabetics
Chris Little, Kent
2:25 - 2:45 Case report - Right-to-left shunting patent ductus arteriosus in a cat
Yolanda Pereira, University of Edinburgh
2:45 - 3:30 Pathology and histopathology of feline cardiomyopathies
Phil Fox, USA
3:30 - 4:00 Coffee
4:00 - 5:00 Panel Discussion: How Do The Experts Treat CHF?
Clarke Atkins, Phil Fox, Mark Patteson, Paul Wotton
COST £85 for members of the VCS, registering before March 17th
£95 for non-members, registering before March 17th
£110 for any delegates registering after March 17th